Tree.com Inc (TREE): Was that the signal to short lol?

Play Episode

8min

Proactive - Interviews for investors

RAD Intel to accellerate growth of AI-powered marketing technology with Reg A+ offering

RAD Intel CEO Jeremy Barnett talked with Proactive's Stephen Gunnion about the company’s AI-powered marketing technology, its latest fundraising round, and rapid business growth. Barnett explained that RAD Intel specializes in artificial intelligence-powered marketing solutions, helping brands deliver the right message to the right audience at the right time. By analyzing historical content patterns, the company enables businesses to optimize their ad spend for maximum return on investment. Discussing major clients, Barnett referenced work with brands like Skechers, Hasbro, and Sweetgreen. He detailed how RAD Intel assisted Hasbro in relaunching a classic brand by aligning messaging with modern audiences and validated Skechers’ Super Bowl ad campaign featuring Mr. T and Tony Romo. The company is currently raising $11.5 million through a Reg A+ offering, with the round closing on June 23, 2025. Barnett said the funds will support RAD Intel’s expansion, including feature development for Omnicom—a major agency client—and acquisitions of small to medium-sized agencies. Barnett also highlighted RAD Intel’s record-breaking Q1 sales, which surpassed all of 2024’s revenue. He attributed this momentum to key contract expansions with Hasbro and Omnicom, as well as increasing market adoption of AI-powered marketing solutions. Watch the full interview for insights into RAD Intel’s growth and AI-driven strategies. Don’t forget to like, subscribe, and enable notifications for more updates from Proactive. #RADIntel #AI #Marketing #ArtificialIntelligence #AdTech #AIinMarketing #DigitalMarketing #JeremyBarnett #Investing #MarketingTech #BusinessGrowth #Startups #Fundraising #AIAdvertising

Proactive - Interviews for investors

St George Mining’s dual track growth plan

St George Mining Ltd executive chairman John Prineas talked with Kerry Stevenson at Proactive about the company's recent acquisition of the Araxá niobium and rare earths project in Brazil. The deal, completed in February, provides St George with an advanced-stage project with high-grade niobium and rare earth elements. Prineas highlighted niobium’s strategic importance, noting that it is primarily used to strengthen steel, with additional applications in medical technology, batteries, and defence. He emphasised the commodity's stable pricing due to limited global supply. The company secured A$20 million in funding to advance the project and is preparing a JORC-compliant mineral resource estimate, expected in the coming weeks. The existing data, based on historical drilling, indicates a 20-year mine life and a US$956 million NPV under a previous non-JORC study. St George aims to optimise the project for niobium, conduct further drilling, and expand the resource. Prineas also addressed Brazil's mining jurisdiction, highlighting strong government support and agreements to expedite approvals. The company is pursuing a dual-track strategy, progressing toward development while ramping up exploration drilling to expand the resource base. Stay tuned for more updates! Visit Proactive's YouTube channel for more interviews, and don’t forget to like, subscribe, and turn on notifications. #StGeorgeMining #ASXSGQ #Niobium #RareEarths #MiningStocks #JORC #BrazilMining #CriticalMetals #ResourceInvestment #BatteryMetals

Proactive - Interviews for investors

Condor Resources CEO discusses 2025 Peru exploration plans

Condor Resources Inc. (TSX-V:CN, OTC:CNRIF) CEO Chris Buncic takes Proactive's Stephen Gunnion through the company’s latest exploration updates in Peru, including progress at Rio Bravo, Huiñac Punta, and Pucamayo East. He highlighted that the company has confirmed a copper-molybdenum porphyry discovery at Rio Bravo, following a February 4 press release, which has led to increased industry interest in potential partnerships. Buncic discussed upcoming drill programs, with a 1,500-meter plan at Huiñac Punta and 2,000 meters at Pucamayo East, set to begin once weather conditions improve. Meanwhile, at Pucamayo Southeast, the company is still awaiting its DIA permit, leading to a temporary shift in focus to fully permitted projects. He also provided an update on Condor’s joint venture with Teck Resources at Cobreorco, where Teck is set to invest $10 million over six years for a 75% stake. Permit approvals are in progress, with drilling expected to commence in the second half of the year. Looking ahead, Buncic sees multiple catalysts, including active drilling campaigns and potential partnership deals. For more updates, visit Proactive’s YouTube channel, like the video, subscribe, and enable notifications. #CondorResources #Mining #Copper #PeruMining #Exploration #MiningNews #Investment #StockMarket #Drilling #TeckResources

Proactive - Interviews for investors

Tonix Pharmaceuticals secures MCDC grant to advance next-gen Mpox & Smallpox vaccine development

Tonix Pharmaceuticals CEO Dr. Seth Lederman joined Steve Darling from Proactive to announce that the company has been awarded a grant from the Medical CBRN Defense Consortium to support the continued development of its next-generation vaccine candidate. MCDC is a consortium comprising industrial, academic, and non-profit organizations that assist the U.S. government in advancing medical solutions to protect against chemical, biological, radiological, and nuclear threats. Dr. Lederman explained that the vaccine candidate is being developed as an improved immunization option for mpox and smallpox, with the potential for delivery via innovative alternative methods designed to enhance patient compliance, ease of administration, and overall tolerability. The MCDC grant will support comprehensive market analyses, target market identification, and commercialization planning for both private and government sectors. The investigational vaccine is a minimally replicating live-virus formulation based on a modified orthopoxvirus. It has demonstrated the ability to provide single-dose immune protection against mpox in preclinical studies while offering improved tolerability compared to traditional live-virus vaccines. Previous studies have also shown its effectiveness in protecting animals from lethal intratracheal exposure to a more virulent strain of the mpox virus. Tonix is currently preparing for Phase 1 clinical trials in both the United States and Kenya. Kenya, which is on the outskirts of an MPOX outbreak in Africa, presents an opportunity to test the vaccine in an area with a growing case burden. #proactiveinvestors #tonixpharmaceuticalsholdingcorp #nasdaq #tnxp #Biotech #MPOXVaccine #Smallpox #TNX801 #VaccineDevelopment #ClinicalTrials #PharmaceuticalNews #MedicalResearch #WHO #GlobalHealth #InfectiousDiseases #Biopharma #ProactiveInvestors

Followers	30
Posts	495
Boards Moderated	0
Alias Born	02/03/2012

Volume:	215,203
Day Range:	50.515 - 53.38
Bid:	50.70
Ask:	51.85
Last Trade Time:	7:11:00 PM EDT
Total Trades:	6,723

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

TREE Detailed Quote

Recent TREE News

More TREE News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent TREE News

Go Ad-Free